To include your compound in the COVID-19 Resource Center, submit it here.

Invitrogen acquiring InforMax

Research tool provider IVGN will acquire INMX for $42 million in

Read the full 118 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE